U.S. Central Venous Catheter Market - by Product Type (Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : May 2019 |
  • Pages : 117 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Central Venous Catheter Market – Increasing Prevalence of Cancer

Central venous catheters play a major role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).

The U.S. central venous catheter market size was valued at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).

Figure 1. U.S. Central Venous Catheter Market Value (US$ Mn), by Design, 2018

U.S. Central Venous Catheter  | Coherent Market Insights

                                                                     Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

Figure 2. U.S. Central Venous Catheter Market Share (%), by Design, 2018 and 2026

U.S. Central Venous Catheter  | Coherent Market Insights

                                                                    Source: Coherent Market Insights Analysis (2018)

Increasing collaboration strategies adopted by market players is expected to bolster growth of the U.S. central venous catheter market

The U.S. central venous catheter market is expected to witness significant growth due to increasing adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped dialysis business of B. Braun Melsungen AG.

Key Players

Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

Central venous catheters consist of a long, thin tube that is inserted into a large vein to deliver medication, nutrition, intravenous fluids, and cancer medications. Different types of central venous catheters can be utilized by patients according to the duration of the treatment. These include, tunneled central venous catheters (CVC) and implanted ports for long term use, peripherally inserted central catheter (PICC) for intermediate term, and non-tunneled CVC for short term use. Central venous catheterization is used for chemotherapy administration, total parenteral nutrition, administration of intravenous fluids and blood, platelet transfusions, and other applications.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving the central venous catheter market growth. According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

Moreover, introduction of innovative products and increasing requirement of long-duration IV therapies such as chemotherapy is expected to boost the market growth. For instance, in May, 2018, Pursuit Vascular, Inc., received the U.S. Food and Drug Administration (FDA) clearance for a broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with central venous catheters (CVCs).

Similarly, in February 2018, the U.S. FDA cleared Access Vasculars’ HydroPICC catheter for peripheral access of the vein.

Key features of the study:

  • This report provides in-depth analysis of the central venous catheter market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the U.S. central venous catheter market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, design up-gradation, market expansion, and marketing tactics
  • The U.S. central venous catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, n1ew entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the central venous catheter market

Detailed Segmentation:

  • U.S. Central Venous Catheter Market, By Product Type:
    • Peripherally Inserted Central Catheters (PICC)
    • Implantable Ports
    • Tunneled Central Venous Catheter
    • Non-tunneled Central Venous Catheter
  • U.S. Central Venous Catheter Market, By Design:
    • Single Lumen
    • Double Lumen
    • Multi Lumen
  • U.S. Central Venous Catheter Market, By Composition:
    • Polyurethane
    • Polyethylene
    • Silicon
  • U.S. Central Venous Catheter Market, By Procedure:
    • Cardiovascular Procedure
    • Chemotherapy Procedure
    • Dialysis Procedure
  • U.S. Central Venous Catheter Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics 
  • Company Profiles
    • AngioDynamics, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • VGXI, Inc.
    • C. R. Bard, Inc.
    • Teleflex Incorporated
    • B. Braun Melsungen AG
    • Medtronic Plc.
    • Vygon Ltd.
    • Cook Medical, Inc.
    • Argon Medical Devices, Inc.
    • ICU Medical, Inc.
    • Theragenics Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Design
      • Market Snippet, By Composition
      • Market Snippet, By Procedure
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers and Acquisitions
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
  4. U.S. Central Venous Catheter  Market, By Product Type, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Peripherally Inserted Central Catheters (PICC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Implantable Ports
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Tunneled Central Venous Catheter
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Non-tunneled Central Venous Catheter
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. U.S. Central Venous Catheter  Market, By Design, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Single Lumen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Double Lumen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Multi Lumen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. U.S. Central Venous Catheter  Market, By Composition, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Polyurethane
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Polyethylene
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Silicon
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. U.S. Central Venous Catheter  Market, By Procedure, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Cardiovascular Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Chemotherapy Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Dialysis Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. U.S. Central Venous Catheter  Market, By End User, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • AngioDynamics, Inc. *
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • C.R. Bard, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teleflex Incorporated
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc
        •  Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vygon Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cook Medical, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Argon Medical Devices, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ICU Medical, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Theragenics Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 38 market data tables and 34 figures on "U.S. Central Venous Catheter Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.